96-96-8

Basic information

• Product Name: Azoic Diazo Component 1
• Synonyms: 4-Methoxy-2-nitroaniline (2-Nitro-p-anisidine);2-nitro-4-Methoxyaniline (4-Methoxy-2-nitroaniline);4-Methoxy-2-nitroaniline, 99%, 99%;sanyofastbordeauxsaltgp;Shinnippon Fast Bordeaux GP Base;shinnipponfastbordeauxgpbase;Sugai Fast Bordeaux GP Base;sugaifastbordeauxgpbase
• CAS NO: 96-96-8
• Molecular Formula: C₇H₈N₂O₃
• Molecular Weight: 168.15
• EINECS: 202-547-2
• Product Categories: Intermediates of Dyes and Pigments;Anilines, Aromatic Amines and Nitro Compounds;Organics
• Mol File: 96-96-8.mol
• Article Data: 38

Chemical Properties

• Melting Point: 123-126 °C(lit.)
• Boiling Point: 337.07°C (rough estimate)
• Flash Point: 158.4 °C
• Appearance: /
• Density: 1.2089 (estimate)
• Vapor Pressure: 9.93E-05mmHg at 25°C
• Refractive Index: 1.6010 (estimate)
• PKA: 0.96±0.10(Predicted)
• Water Solubility: slightly soluble
• BRN: 880318
• CAS DataBase Reference: Azoic Diazo Component 1(CAS DataBase Reference)
• NIST Chemistry Reference: Azoic Diazo Component 1(96-96-8)
• EPA Substance Registry System: Azoic Diazo Component 1(96-96-8)

Safety Data

• Hazard Codes: T+,T
• Statements: 26/27/28-33-52/53
• Safety Statements: 28-36/37-45-61
• RIDADR: UN 2811 6.1/PG 2
• WGK Germany: 2
• RTECS: BY4415000
• TSCA: Yes
• HazardClass: 6.1
• PackingGroup: II
• Hazardous Substances Data: 96-96-8(Hazardous Substances Data)

Usage

Chemical Properties

orange crystalline powder

Uses

Different sources of media describe the Uses of 96-96-8 differently. You can refer to the following data:
1. Toxic to some wild and domestic birds and mice. Molluscicidal activity
2. 4-Methoxy-2-nitroaniline is an aniline compound used in the synthesis of dyes and pigments. It has also been shown to act as a molluscicidal agent and has been used in hemolytic anemia studies. Also used as an intermediate for the synthesis of dyes, pigments and other chemical compounds.

Definition

ChEBI: A substituted aniline that is 3-nitroanisole in which the hydrogen para to the methoxy group is replaced by an amino group.

InChI:InChI=1/C7H8N2O3/c1-12-5-2-3-6(8)7(4-5)9(10)11/h2-4H,8H2,1H3

Upstream product

• 67-56-1 methanol 
• 119-81-3 4-methoxy-2-nitroacetanilide 
• 65183-00-8 N-(4-methoxy-2-nitro-phenyl)-thioacetamide 
• 7664-93-9 sulfuric acid 
• 3223-77-6 2-chloro-N-(4-methoxy-2-nitrophenyl)acetamide 
• 19871-36-4 N-acetyl-4-methoxy-2-nitro-N-(toluene-4-sulfonyl)-aniline 
• 147378-71-0 (4-methoxy-2-nitro-phenyl)-carbamic acid ethyl ester 
• 349099-71-4 2-nitro-toluene-4-sulfonic acid-(4-methoxy-2-nitro-anilide) 
• 431074-97-4 N-acetyl-N-(toluene-4-sulfonyl)-p-anisidine 
• 10336-13-7 1-azido-4-methoxy-2-nitrobenzene 
• 14990-93-3 N-(4-methoxyphenyl)-2-pyridinecarboxamide 
• 7160-02-3 N-(4-methoxyphenyl)-N',N'-dimethylurea 
• 5416-93-3 4-Methoxyphenyl isocyanate 
• 137379-63-6 (4-methoxy-phenyl)-pyrimidin-2-yl-amine 

Downstream Products

• 109471-77-4 2-(4-methoxy-2-nitro-phenyl)-benz[de]isoquinoline-1,3-dione 
• 64376-06-3 acetoacetic acid-(4-methoxy-2-nitro-anilide) 
• 38259-63-1 N-(4-methoxy-2-nitrophenyl)benzamide 
• 64992-56-9 6-methoxy-4-methyl-8-nitroquinoline 
• 85-81-4 6-methoxy-8-nitroquinoline 
• 54232-06-3 6-methoxy-2-methyl-8-nitroquinoline 
• 3360-85-8 N-ethyl-(4-methoxy-2-nitrophenyl)amine 
• 86844-77-1 (1S,2R,6S,7R)-4-(4-Methoxy-2-nitro-phenyl)-10-oxa-4-aza-tricyclo[5.2.1.0^2,6]decane-3,5-dione 
• 172162-01-5 N-(4-methoxy-2-nitrophenyl)-2-(N-hydroxyimino)acetamide 
• 61690-45-7 4-methoxy-2-nitrophenylhydrazine 
• 13838-44-3 ethyl 5-methoxy-7-nitro-1H-indole-2-carboxylate 
• 185428-90-4 (4-methoxy-2-nitro-phenyl)-carbamic acid tert-butyl ester 
• 3360-79-0 N-methyl-4-methoxy-2-nitroaniline 
• 132445-60-4 N-(4-methoxy-2-nitrophenyl)-4-methylquinolin-2-amine 

Relevant articles and documents

Fused tricyclic derivative as FGFR4 inhibitor

The present invention provides a fused tricyclic derivative that is the selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), a pharmaceutical composition containing the compound, a method of making the compound and a method of treating cell proliferative diseases, such as cancer, using the compounds of the invention.

Sodium persulfate-promoted site-selective synthesis of mononitroarylamines under transition-metal-free conditions

A practical preparation of nitroarylamines from protected arylamines was herein disclosed. In this system, sodium nitrite acted as a nitration reagent in the presence of sodium persulfate without any transition-metal catalysts. This efficient site-selective protocol took place at room temperature for a short time through a free radical pathway.

NOVEL FYN KINASE INHIBITORS

The present invention relates to the novel therapies to treat neurodegenerative diseases such as Parkinson's disease (PD). The present invention relates to novel small molecule inhibitors of Fyn Kinase and for testing activity against Parkinsons's disease models compounds that inhibit Fyn kinase having the following formula. (I)